Pennsylvania Lands $3.2M for Hershey PGx Center | GenomeWeb

NEW YORK (GenomeWeb News) – The Penn State Hershey Cancer Institute will use $3.2 million in federal funding to start a new pharmacogenomics research center that will serve as a sample repository and research center for the institute, the university said this week.

The Penn State Center for Pharmacogenetics will house the cancer institute's samples and will be a resource and research center for translational studies focused on oncology drugs and prevention approaches.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.